Patrick Gage Insider Profile
11 Followers
Patrick Gage, Director at Cytokinetics, holds 30.78K shares in Cytokinetics (Ticker: CYTK), holds 38.88K shares in Tetraphase (Ticker: TTPH), holds 19.55K shares in PDL BioPharma (Ticker: PDLI).
Patrick Gage's Trading History
| CYTKCytokinetics | Nov 08, 2021 | Director | Uninformative Buy | 112.40K | $1.73M | |
| TTPHTetraphase | Dec 04, 2017 | ― | Informative Buy | 25.03K | $88.65K | |
| PDLIPDL BioPharma | ― | ― | ― | $48.30K |
You May Also Like
Patrick Gage insider profile FAQ
What is the percentage of profitable transactions made by Patrick Gage?
The percentage of profitable transactions made by Patrick Gage is 61%.
What is the average return per transaction made by Patrick Gage?
The average return per transaction made by Patrick Gage is 71.80%.
What stocks does Patrick Gage hold?
Patrick Gage holds: CYTK, TTPH, PDLI stocks.
What was Patrick Gage’s latest transaction?
Patrick Gage’s latest transaction was an Uninformative Buy of $112.40K.
What was Patrick Gage's most profitable transaction?
Patrick Gage’s most profitable transaction was an Informative Buy of TTPH stock on May 16, 2014. The return on the trade was 352.70%.
What is Patrick Gage's role in Cytokinetics?
Patrick Gage's role in Cytokinetics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
